Ranking · Winter 2026 · B2B

10x Science

The AI-native platform for next-generation protein characterization.

9.3%

odds of being acquired in the next two years

1.4× the average (6.8%)

#608 of 4,339 active YC companies · top 15%

Team of 5 · San Francisco, CA, USA

Raises the odds

↑ “platform” in its one-liner

↑ industry: B2B

↑ tag: SaaS

↑ team of 3–5

Lowers the odds

↓ under 1.5 years since YC

↓ tag: AI

↓ tag: Biotech

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads 10x Science's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

10xscience.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub